Pubblicazioni

Pharmacogenomics-Guided Pharmacotherapy in Patients with Major Depressive Disorder or Bipolar Disorder Affected by Treatment-Resistant Depressive Episodes. A Long-Term Follow-up Study

2022 - JOURNAL OF PERSONALIZED MEDICINE

Del Casale, Antonio; Pomes, Leda Marina; Bonanni, Luca; FiaschÃ¨, Federica; Zocchi, Clarissa; Padovano, Alessio; De Luca, Ottavia; Angeletti, Gloria; Brugnoli, Roberto; Girardi, Paolo; Preissner, Robert; Borro, Marina; Gentile, Giovanna; Pompili, Maurizio; Simmaco, Maurizio

How does IL-6 change after combined treatment in MDD patients? A systematic review

2022 - BRAIN, BEHAVIOR, & IMMUNITY. HEALTH

Lombardi, AURORA LEONTINA; Manfredi, Lucia; Conversi, David

A revision on the effectiveness of omega-3 polyunsaturated fatty acids as monotherapy in the treatment of major depressive disorder

2022 - INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Accinni, T.; Panfili, M.; Tarsitani, L.; Biondi, M.; Pasquini, M.; Maraone, A.

Transcriptional biomarkers of response to pharmacological treatments in severe mental disorders: A systematic review

2022 - EUROPEAN NEUROPSYCHOPHARMACOLOGY

Pisanu, C.; Severino, G.; De Toma, I.; Dierssen, M.; Fusar-Poli, P.; Gennarelli, M.; Lio, P.; Maffioletti, E.; Maron, E.; Mehta, D.; Minelli, A.; Potier, M. -C.; Serretti, A.; Stacey, D.; van Westrhenen, R.; Xicota, L.; Baune, B. T.; Squassina, A.